Methylphenidate
CNS stimulant used for ADHD and narcolepsy.
Methylphenidate, sold under brand names such as Ritalin and Concerta, is a central nervous system stimulant belonging to the phenethylamine and piperidine chemical classes. Its primary medical uses are the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy, a chronic sleep condition marked by excessive daytime drowsiness. For ADHD, the drug is thought to work by blocking the reuptake of dopamine and norepinephrine in the brain, thereby increasing the activity of these neurotransmitters. This action is believed to reduce core ADHD symptoms like hyperactivity and impulsivity while improving alertness, concentration, and aspects of executive function such as working memory, sustained attention, and inhibitory control. The medication is available in immediate-release and modified-release oral formulations, as well as a transdermal patch applied to the skin, with different formulations producing effects that last for varying durations. While its effectiveness for ADHD is generally comparable to the non-stimulant atomoxetine, it is modestly less effective than amphetamine-based medications. Despite this, methylphenidate is typically preferred as a first-line treatment in children, whereas amphetamines are more often chosen for adults. Common side effects at therapeutic doses include loss of appetite, weight loss, sleep difficulties, and small increases in heart rate and blood pressure. Long-term use in children has been linked to slightly slower growth. Misuse, dependence, and withdrawal are primarily associated with high-dose or non-medical use and are uncommon when taken as prescribed. The drug is also available as a generic medication.
- field
- Pharmacology, Psychiatry
- known_for
- Treatment of ADHD and narcolepsy
- common_brand_names
- Ritalin, Concerta
- drug_class
- CNS stimulant (phenethylamine and piperidine classes)
- mechanism
- Blocks reuptake of dopamine and norepinephrine
Lore & Background
Methylphenidate is a central nervous system stimulant belonging to the phenethylamine and piperidine classes. It is believed to work by blocking the reuptake of the neurotransmitters dopamine and norepinephrine, thereby increasing their activity in the brain. The drug is available in immediate-release and modified-release formulations, which can be taken by mouth or applied to the skin, with effects lasting several hours depending on the specific formulation and individual patient response. In clinical use for attention deficit hyperactivity disorder (ADHD), methylphenidate reduces core symptoms such as hyperactivity and impulsive behavior while improving alertness, concentration, and aspects of executive function including working memory, sustained attention, and inhibitory control. Common side effects at therapeutic doses include loss of appetite, weight loss, trouble sleeping, and small increases in heart rate and blood pressure; long-term use in children has been associated with slightly slower growth. Misuse, dependence, and withdrawal are mainly reported with high-dose or non-medical use and are uncommon at prescribed doses. Large-scale meta-analyses have found no statistically significant association between ADHD medications, including methylphenidate, and the risk of cardiovascular events across age groups. Long-term treatment has been associated with improved brain development and functioning, particularly in inferior frontal and striatal regions, rather than deficits in brain structure. The drug is also used to treat narcolepsy, where it is considered effective in increasing wakefulness, vigilance, and performance.
Reader's Guide
Methylphenidate's significance lies in its widespread use as a first-line medication for ADHD, particularly in children, and its role in treating narcolepsy. The International Consensus Statement on ADHD describes it as among the most efficacious drugs in all of medicine, with long-term treatment substantially reducing accidental injuries, substance abuse, depression, and other adverse outcomes. Professional groups such as the European Society for Child and Adolescent Psychiatry and the American Academy of Pediatrics endorse its use. Common side effects include loss of appetite, weight loss, trouble sleeping, and small increases in heart rate and blood pressure; long-term use in children is associated with slightly slower growth. Misuse, dependence, and withdrawal are mainly reported with high-dose or non-medical use.
Did You Know?
- Methylphenidate is believed to work by blocking the reuptake of dopamine and norepinephrine by neurons.
- Long-term treatment in children has been associated with slightly slower growth.
More in Medications And Drugs 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record